The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project
Conroy, R. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00114-3 · Cited by 5,290
D'Agostino, R. B., Grundy, S., Sullivan, L. M., Wilson, P., & for the CHD Risk Prediction Group (2001) · JAMA · doi:10.1001/jama.286.2.180 · Cited by 2,108
Assmann, G., Cullen, P., & Schulte, H. (2002) · Circulation · doi:10.1161/hc0302.102575 · Cited by 1,541
Obesity and Vascular Risk Factors at Midlife and the Risk of Dementia and Alzheimer Disease
Kivipelto, M., Ngandu, T., Fratiglioni, L., Viitanen, M., Kåreholt, I., Winblad, B., Helkala, E.-L., Tuomilehto, J., Soininen, H., & Nissinen, A. (2005) · Archives of Neurology · doi:10.1001/archneur.62.10.1556 · Cited by 1,291
Self-citationMidlife blood pressure and dementia: the Honolulu–Asia aging study☆
Launer, L. J., Ross, G. W., Petrovitch, H., Masaki, K., Foley, D., White, L. R., & Havlik, R. J. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00096-8 · Cited by 1,008
Forette, F. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.18.2046 · Cited by 898
Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies
Andersen, K., Launer, L. J., Dewey, M. E., Letenneur, L., Ott, A., Copeland, J. R. M., Dartigues, J.-F., Kragh–Sorensen, P., Baldereschi, M., Brayne, C., et al. (1999) · Neurology · doi:10.1212/wnl.53.9.1992 · Cited by 650
Kalmijn, S., Foley, D., White, L., Burchfiel, C. M., Curb, J. D., Petrovitch, H., Ross, G. W., Havlik, R. J., & Launer, L. J. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.10.2255 · Cited by 417
Antihypertensive drugs and incidence of dementia: the Rotterdam Study
in’t Veld, B. A., Ruitenberg, A., Hofman, A., Stricker, B. H. C., & Breteler, M. M. B. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00241-4 · Cited by 254
Research works printed but not linked: 31
- Jorm, 1998, The incidence of dementia: a meta-analysis, Neurology, 51, 728, 10.1212/WNL.51.3.728 · DOI · Paper page
- Fratiglioni, 1999, Worldwide prevalence and incidence of dementia, Drugs Aging, 15, 365, 10.2165/00002512-199915050-00004 · DOI · Paper page
- Chambless, 2003, Coronary heart disease risk prediction in the Atherosclerosis risk in communities (ARIC) study, J Clin Epidemiol, 56, 880, 10.1016/S0895-4356(03)00055-6 · DOI · Paper page
- 1991, Prediction of coronary heart disease in Europe. The 2nd report of the WHO-ERICA Project, Eur Heart J, 12, 291, 10.1093/oxfordjournals.eurheartj.a059893 · DOI
- Tunstall-Pedoe, 1991, The Dundee coronary risk-disk for management of change in risk factors, BMJ, 303, 744, 10.1136/bmj.303.6805.744 · DOI
- Pocock, 2001, A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials, BMJ, 323, 75, 10.1136/bmj.323.7304.75 · DOI · Paper page
- Lindström, 2003, The diabetes risk score: a practical tool to predict type 2 diabetes risk, Diabetes Care, 26, 725, 10.2337/diacare.26.3.725 · DOI · Paper page
- Haq, 1999, Is the Framingham risk function valid for northern European populations? A comparison of methods for estimating absolute coronary risk in high risk men, Heart, 81, 40, 10.1136/hrt.81.1.40 · DOI
- Bastuji-Garin, 2002, The Framingham prediction rule is not valid in a European population of treated hypertensive patients, J Hypertens, 20, 1973, 10.1097/00004872-200210000-00016 · DOI
- Knuiman, 1997, Prediction of coronary heart disease mortality in Busselton, Western Australia: an evaluation of Framingham, national health epidemiologic follow-up study, and WHO ERICA risk scores, J Epidemiol Community Health, 51, 515, 10.1136/jech.51.5.515 · DOI
- Hall, 2003, Controlled trial of effect of documented cardiovascular risk scores on prescribing, BMJ, 326, 251, 10.1136/bmj.326.7383.251 · DOI
- Gustafson, 2003, An 18-year follow-up of overweight and risk of Alzheimer disease, Arch Intern Med, 163, 1524, 10.1001/archinte.163.13.1524 · DOI · Paper page
- Skoog, 1996, 15-year longitudinal study of blood pressure and dementia, Lancet, 347, 1141, 10.1016/S0140-6736(96)90608-X · DOI · Paper page
- Kivipelto, 2001, Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study, BMJ, 322, 1447, 10.1136/bmj.322.7300.1447 · DOI · Paper page
- Ott, 1996, Association of diabetes mellitus and dementia: the Rotterdam study, Diabetologia, 39, 1392, 10.1007/s001250050588 · DOI · Paper page
- Kivipelto, 2001, Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study, Neurology, 56, 1683, 10.1212/WNL.56.12.1683 · DOI · Paper page
- Puska, 1979, Changes in coronary risk factors during comprehensive five-year community programme to control cardiovascular diseases (North Karelia Project), BMJ, 2, 1173, 10.1136/bmj.2.6199.1173 · DOI · Paper page
- Puska, 1983, Change in risk factors for coronary heart disease during 10 years of a community intervention programme (The North Karelia Project), BMJ, 287, 1840, 10.1136/bmj.287.6408.1840 · DOI
- Vartiainen, 1994, Twenty-years trends in coronary risk factors in North-Karelia and in other areas of Finland, Int J Epidemiol, 23, 495, 10.1093/ije/23.3.495 · DOI · Paper page
- Tsukamoto, 1993, Determination by PCR-RFLP of apoE genotype in a Japanese population, J Lab Clin Med, 121, 598
- McKhann, 1984, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology, 34, 939, 10.1212/WNL.34.7.939 · DOI · Paper page
- Chobanian, 2003, The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The JNC 7 Report, JAMA, 289, 2560, 10.1001/jama.289.19.2560 · DOI · Paper page
- Pyörälä, 1994, Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension, Atherosclerosis, 110, 121, 10.1016/0021-9150(94)90200-3 · DOI · Paper page
- Qiu, 2003, Combined effects of APOE genotype, blood pressure, and antihypertensive drug use on incident AD, Neurology, 61, 655, 10.1212/WNL.61.5.655 · DOI
- Rockwood, 2002, Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people, Arch Neurol, 59, 223, 10.1001/archneur.59.2.223 · DOI · Paper page
- Jick, 2000, Statins and the risk of dementia, Lancet, 356, 1627, 10.1016/S0140-6736(00)03155-X · DOI · Paper page
- Tzourio, 2003, Effects of blood pressure lowering with perindopil and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease, Arch Intern Med, 163, 1069, 10.1001/archinte.163.9.1069 · DOI · Paper page
- Forette, 1998, Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial, Lancet, 352, 1347, 10.1016/S0140-6736(98)03086-4 · DOI · Paper page
- 1991, Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP), JAMA, 265, 3255, 10.1001/jama.1991.03460240051027 · DOI · Paper page
- Prince, 1996, Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults, BMJ, 312, 801, 10.1136/bmj.312.7034.801 · DOI · Paper page
- Lithell, 2003, The study on cognition and prognosis in the elderly (SCOPE): principal results of a randomised double-blind intervention trial, J Hypertens, 21, 875, 10.1097/00004872-200305000-00011 · DOI · Paper page
Cited by
Dementia prevention, intervention, and care
Livingston, G., Sommerlad, A., Orgeta, V., Costafreda, S. G., Huntley, J., Ames, D., Ballard, C., Banerjee, S., Burns, A., Cohen-Mansfield, J., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31363-6 · Cited by 6,072
Ngandu, T., Lehtisalo, J., Solomon, A., Levälahti, E., Ahtiluoto, S., Antikainen, R., Bäckman, L., Hänninen, T., Jula, A., Laatikainen, T., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60461-5 · Cited by 3,689
Self-citationLibby, P., Buring, J. E., Badimon, L., Hansson, G. K., Deanfield, J., Bittencourt, M. S., Tokgözoğlu, L., & Lewis, E. F. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0106-z · Cited by 3,211
Defeating Alzheimer's disease and other dementias: a priority for European science and society
Winblad, B., Amouyel, P., Andrieu, S., Ballard, C., Brayne, C., Brodaty, H., Cedazo-Minguez, A., Dubois, B., Edvardsson, D., Feldman, H., et al. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)00062-4 · Cited by 1,676
Self-citationEpidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention
Qiu, C., Kivipelto, M., & von Strauss, E. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.2/cqiu · Cited by 1,261
Self-citation
Metadata
- Authors
- Kivipelto, M., Ngandu, T., Laatikainen, T., Winblad, B., Soininen, H., & Tuomilehto, J.
- Venue
- The Lancet Neurology
- Publisher
- Elsevier BV
- Published
- 2006-09
- Volume
- 5
- Issue
- 9
- Pages
- 735-741
- ISSN
- 1474-4422 (ISSN-L)
- OpenAlex
- W2098706789
- Cited by
- 1,126
- References
- 11
- FWCI
- 15.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
